Jakafi Prices, Coupons, Copay Cards & Patient Assistance
Jakafi (ruxolitinib) is a member of the multikinase inhibitors drug class and is commonly used for Graft-versus-host disease, Myelofibrosis, Myeloproliferative Disorders, and others.
The cost for Jakafi 5 mg oral tablet is around $18,400 for a supply of 60 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Jakafi is available as a brand name drug only, a generic version is not yet available. View generic Jakafi availability for more details.
Jakafi prices
Oral Tablet
5 mg
Jakafi oral tablet
from $18,400.15
for 60 tablets
Quantity | Per unit | Price |
---|---|---|
60 | $306.67 | $18,400.15 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
10 mg
Jakafi oral tablet
from $18,400.15
for 60 tablets
Quantity | Per unit | Price |
---|---|---|
60 | $306.67 | $18,400.15 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
15 mg
Jakafi oral tablet
from $18,400.15
for 60 tablets
Quantity | Per unit | Price |
---|---|---|
60 | $306.67 | $18,400.15 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
20 mg
Jakafi oral tablet
from $18,400.15
for 60 tablets
Quantity | Per unit | Price |
---|---|---|
60 | $306.67 | $18,400.15 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
25 mg
Jakafi oral tablet
from $18,400.15
for 60 tablets
Quantity | Per unit | Price |
---|---|---|
60 | $306.67 | $18,400.15 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Jakafi Coupons, Copay Cards and Rebates
Jakafi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Jakafi Patient Copay/Coinsurance Assistance
Eligible commercially insured patients may pay $0 per month with savings of $11,977 per fill.
- Applies to:
- Jakafi
- Number of uses:
- per prescription per year
Form more information phone: 855-452-5234 or Visit website
Jakafi Temporary Coverage
Eligible commercially insured patients may receive a FREE short-term supply of medication if experiencing a delay in insurance coverage.
- Applies to:
- Jakafi
- Number of uses:
- Temporary Assistance
Form more information phone: 855-452-5234 or Visit website
Patient Assistance & Copay Programs for Jakafi
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Jakafi (ruxolitinib) Tablet
More information please phone: 800-675-8416 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Jakafi (ruxolitinib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: IncyteCARES for Jakafi Patient Assistance Program
Eligibility requirements:- Must be uninsured or underinsured
- Varies
- FDA-approved diagnosis
- Must be residing in the US or Puerto Rico
- Patient or doctor's office can call the program to apply. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Conditional approval for 90 days. Education and support services are available. This program also provides copay/coinsurance assistance for commercially/privately insured patients Prescribers can enroll the patient online via the IncyteCARES.com website. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Jakafi (ruxolitinib) Tablet
More information please phone: 855-452-5234 Visit Website
Provider: Good Days Program
Eligibility requirements:- Must have insurance
- At or below 500% of FPL
- FDA-approved diagnosis
- The patient must also be a US resident with a Social Security Number.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
- Jakafi (ruxolitinib) Tablet
More information please phone: 877-968-7233 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Jakafi (ruxolitinib)
- Check interactions
- Compare alternatives
- Reviews (33)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español